5 EASY FACTS ABOUT KT-474 DESCRIBED

Dosages should be individualized in accordance with the advisable aim of therapy and the affected person’s response.Rhabdomyolysis with renal dysfunction secondary to myoglobinuria have been reported with other HMG-CoA reductase inhibitors. This has not been noted with cerivastatin sodium up to now. Cerivastatin therapy needs to be discontinued i